Trial intelligence / Profile preview

Intravenous lidocaine and neuroinflammation in colorectal surgery via RAAS pathway

ChiCTR2200055683Phase 4Recruiting

Sponsor
Changde First People's Hospital
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in colorectal cancer (CRC) comparing Intravenous lidocaine arm with Normal saline placebo arm (2 arms). Primary endpoints: Interleukin 6, Interleukin 8 and 2 more. Started Jan 2022; status: recruiting.

02

Drugs

lidocaine
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on ChiCTR2200055683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200055683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call